reports
Leadership Changes
Leadership Changes THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. Cambridge, UK, 10 February 2026 – 4basebio PLC (AIM: 4BB), an innovation driven biotechnology company enabling and accelerating development of advanced therapy medicinal products (ATMPs) through its high performant GMP-grade synthetic DNA products, announces that Dr Amy Walker has been appointed as Chief Executive Officer, succeeding Dr Heikki Lanckriet, Founder ...
Axogen, Inc. to Report Fourth Quarter and Full Year 2025 Financial Res...
Axogen, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 ALACHUA, Fla. and TAMPA, Fla., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that it will release financial results for the fourth quarter and full year 2025 on Tuesday, February 24, 2026. Axogen management will host an investment-community conference call and webcast at 8:00 a.m. ET following the release. Investors interested in participa...
Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financ...
Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 BOSTON, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that it will publish fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026, after U.S. market close. About Standard BioTools Inc. Standard BioTools Inc. (Nasdaq: LAB), has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop better medicines faster. As a leading solutions provider, the comp...
Bread Financial Provides Performance Update for January 2026
Bread Financial Provides Performance Update for January 2026 COLUMBUS, Ohio, Feb. 10, 2026 (GLOBE NEWSWIRE) -- (NYSE: BFH), a tech-forward financial services company that provides simple, personalized payment, lending, and saving solutions to millions of U.S. consumers, provided a performance update. The following tables present the Company’s Net principal loss rate and Delinquency rate for the periods indicated: For themonth endedJanuary 31, 2026 For themonth endedJanuary 31, 2025 (dollars in millions)End-of-period credit card and other loans$18,386 $18,366 Average credit card and oth...
New Flyer receives order for 100 additional transit buses for the Wash...
New Flyer receives order for 100 additional transit buses for the Washington Metro Region Washington Metro continues to modernize its fleet with New Flyer hybrid and battery-electric buses ST. CLOUD, Minn., Feb. 10, 2026 (GLOBE NEWSWIRE) -- (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) New Flyer of America Inc. (New Flyer), a leader in the transit industry and a subsidiary of NFI Group Inc. (NFI), today announced that Washington Metropolitan Area Transit Authority (“Metro”) has exercised options for 75 Xcelsior® hybrid-electric forty-foot transit buses and 25 Xcelsior CHARGE NG™ battery-electr...
Regeneron Highlights Expanding Immunology Portfolio and Pipeline at AA...
Regeneron Highlights Expanding Immunology Portfolio and Pipeline at AAAAI, Showcasing Novel Approaches to Treating Allergy 36 abstracts to be presented across Regeneron-invented therapies, including first-time Phase 3 presentations for two distinct investigational allergen-blocking antibodies for cat and birch allergies New Dupixent® (dupilumab) data highlight its clinical and real-world impact across dermatological, respiratory and gastrointestinal diseases, including analyses of food allergy sensitization in children with atopic dermatitis TARRYTOWN, N.Y., Feb. 10, 2026 (GLOBE NEWSWIR...
Lee Enterprises Reports Strong First Quarter Results and Closing of St...
Lee Enterprises Reports Strong First Quarter Results and Closing of Strategic Investment Q1 Adjusted EBITDA(1) growth of $5M or 61% YOY$50M equity investment(2) enhances financial stabilityInterest rate on outstanding debt reduced to 5% from 9%(3) DAVENPORT, Iowa, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Lee Enterprises, Incorporated (NASDAQ: LEE), a digital-first subscription platform providing high quality, trusted, local news, information and a major platform for advertising in 72 markets, today reported preliminary first quarter fiscal 2026 financial results(4) for the period ended Dece...
Datadog Announces Fourth Quarter and Fiscal Year 2025 Financial Result...
Datadog Announces Fourth Quarter and Fiscal Year 2025 Financial Results Fourth quarter revenue grew 29% year-over-year to $953 million Strong growth of larger customers, with 603 $1 million+ ARR customers, up from 462 a year ago Launched Bits AI SRE Agent, Storage Management, Feature Flags, and Data Observability for general availability NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Datadog, Inc. (NASDAQ:DDOG), the AI-powered observability and security platform for cloud applications, today announced financial results for its fourth quarter and fiscal year ended Decembe...
Fiserv Reports Fourth Quarter and Full Year 2025 Results
Fiserv Reports Fourth Quarter and Full Year 2025 Results GAAP revenue growth of 1% in the quarter and 4% for the full year;GAAP EPS decreased 8% in the quarter and increased 18% for the full year;Organic revenue was flat in the quarter and increased 4% for the full year;Adjusted EPS decreased 21% in the quarter and 2% for the full year;Company expects 2026 organic revenue growth of 1% to 3%and adjusted EPS of $8.00 to $8.30 MILWAUKEE, Wis., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Fiserv, Inc. (NASDAQ: FISV), a leading global provider of payments and financial services technology solutions, tod...
ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter...
ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer Brings 20+ years of clinical development experience in autoimmune and inflammatory diseases, including OX40/OX40L program leadership Will build and lead Imagene’s clinical organization and drive completion of the Phase 2b ADAPTIVE trial in atopic dermatitis Will expand Phase 2b trial footprint with planned international sites including in the UK and Europe SAN DIEGO, Feb. 10, 2026 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq: IMA, “Imagene,” or the “Company”), today announced the appoi...
Abaxx Digital Title Pilots Achieve T+0 Collateral Mobilization for Gol...
Abaxx Digital Title Pilots Achieve T+0 Collateral Mobilization for Gold and Yield-Bearing Securities Abaxx’s proprietary market infrastructure innovation demonstrates that identity-anchored digital instruments can deliver T+0 finality and capital efficiency while reducing the regulatory risks and cross-jurisdictional ownership uncertainties inherent in blockchain tokenization TORONTO, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. (CBOE:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, majority shareholder of Abaxx Singapor...
Manhattan Bridge Capital, Inc. Declares Quarterly Dividend
Manhattan Bridge Capital, Inc. Declares Quarterly Dividend GREAT NECK, N.Y., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Manhattan Bridge Capital, Inc. (NASDAQ: ) announced today that its board of directors has declared a quarterly dividend of $0.11 per share to be paid to all shareholders of record on April 8, 2026. The dividend will be paid on April 15, 2026. Contact: Assaf Ran, CEO (516) 444-3400 SOURCE: Manhattan Bridge Capital, Inc.
Apellis Pharmaceuticals to Host Conference Call on February 24, 2026, ...
Apellis Pharmaceuticals to Host Conference Call on February 24, 2026, to Discuss Fourth Quarter and Full Year 2025 Financial Results WALTHAM, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) -- , Inc. (Nasdaq: APLS) today announced that the company will host a conference call and webcast to discuss its fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026 at 8:30 a.m. ET. To access the live call by phone, please pre-register for the call . A live audio webcast of the event and accompanying slides may also be accessed through the “Events and Presentations” page of the “In...
European Wax Center to Be Taken Private by General Atlantic in All-Cas...
European Wax Center to Be Taken Private by General Atlantic in All-Cash Transaction Stockholders to Receive $5.80 Per Share in Cash PLANO, Texas, Feb. 10, 2026 (GLOBE NEWSWIRE) -- European Wax Center, Inc. (NASDAQ: EWCZ) (the “Company” or “European Wax Center”), a leading franchisor and operator of out-of-home waxing services in the United States, today announced that it has entered into a definitive agreement to be taken private by General Atlantic, a leading global investor, in an all-cash transaction with an implied equity value of approximately $330 million. General Atlantic has be...
Sirios recoupe 0,26 g/t en or sur 298,2 mètres à Aquilon
Les résultats d'échantillonnage confirment la continuité du halo aurifère à fort potentiel du projet, Eeyou Istchee Baie-James, QuébecMontréal, Québec--(Newsfile Corp. - 10 février 2026) - Ressources Sirios inc. (TSXV: SOI) présente les résultats d'analyses du programme additionnel d'échantillonnage sur 1 496 mètres de carottes de forage du projet aurifère Aquilon, dans la région d'Eeyou Istchee Baie-James, au Québec. Les résultats de six trous de forage, échantillonnés en continu sur toute la longueur des carottes, précisent davantage le . Le halo s'étend latéralement sur plus de 700 m du sud...
Macerich Schedules Fourth Quarter 2025 Earnings Release and Conference...
Macerich Schedules Fourth Quarter 2025 Earnings Release and Conference Call SANTA MONICA, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- WHAT: Macerich (NYSE: MAC) Schedules Fourth Quarter 2025 Earnings Release and Conference Call WHEN: Earnings Results will be released after market on Wednesday, February 18, 2026. Management will hold a conference call at 2:00 pm Pacific Time (5:00 pm Eastern Time) on that same day to discuss quarterly results. WHERE: Participants who wish to join the conference by telephone must register using the dial-in registration link below to receive the dial-in nu...
Aeluma Names Bouchaib Nessar Senior Vice President of Business Develop...
Aeluma Names Bouchaib Nessar Senior Vice President of Business Development and Product Key Appointment to Drive Commercialization Strategy as Markets Ramp and Company Generates Initial Sales GOLETA, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Aeluma, Inc. (NASDAQ: ALMU), a semiconductor company specializing in high-performance, scalable technologies for mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum, announced today it has named Bouchaib Nessar as its Senior Vice President of Business Development and Product to lead its go-to-market strategy across communicati...
Aurora Mobile’s GPTBots.ai and Hong Kong Ants Asia Forge Strategic Par...
Aurora Mobile’s GPTBots.ai and Hong Kong Ants Asia Forge Strategic Partnership for AI Innovation HONG KONG, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services in China, today announced that its enterprise-grade AI agent platform, , has established a strategic partnership with Ants Asia Limited, a leading enterprise AI solutions specialist deeply rooted in the Hong Kong market. This collaboration combines GPTBots.ai’s powerful no-code infrastructure with Ants As...
Sutro Biopharma Announces Pricing of $110.0 million Underwritten Offer...
Sutro Biopharma Announces Pricing of $110.0 million Underwritten Offering SOUTH SAN FRANCISCO, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (Nasdaq: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced the pricing of an underwritten offering of 7,868,383 shares of its common stock at a price of $13.98 per share. The gross proceeds from this offering are expected to be approximately $110.0 million, before deducting underwriting discounts and commissions and other offerin...
Bahrain Cinema Company B S C: 1 director
A director at Bahrain Cinema Company B S C bought 50,734 shares at 0.213BHD and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.